Zebulun D. Horowitz
Keine laufenden Positionen mehr
Profil
Zebulun D.
Horowitz joined Savient Pharmaceuticals, Inc. in March 2003 as Senior Vice President and Chief Medical Officer.
Previously, he served as an Executive Director of Global Clinical Research and Development for Novartis Pharmaceuticals, which he joined in 1996.
Dr. Horowitz was Principal Scientist and Medical Director of New Drug Development for Procter & Gamble Pharmaceuticals from 1992 to 1996 and an Associate Professor of Clinical Medicine at the University of Cincinnati College of Medicine from 1989 to 1996.
He was Section Chief and Consultant in Endocrinology, Diabetes and Metabolism for the Veterans Administration Medical Center from 1989 to 1996.
Dr. Horowitz served as an Assistant Professor of Medicine and Assistant Attending Physician at the New York University School of Medicine for the Bellevue Hospital Medical Center from 1983 to 1989 and Attending Physician in Endocrinology, Diabetes and Metabolism for New Gouverneur Hospital from 1982 to 1984.
He received a BA from Reed College in 1974 and an MD from the New York University School of Medicine in June 1978.
Ehemalige bekannte Positionen von Zebulun D. Horowitz
| Unternehmen | Position | Ende |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 19.06.2009 |
Procter & Gamble Pharmaceuticals, Inc.
 Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Procter & Gamble Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its products include Actonel, Asacol, Enablex, Didronel, Macrobid, Macrodantin, Entex, and Ziac. The firm manufactures and markets a variety of over-the-counter and oral care products such as Crest, Oral-B, Prilosec OTC, Vicks, Metamucil, Pepto-Bismol, ThermaCare, and other related products. The company was founded in 1970 and is headquartered in Cincinnati, OH. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1996 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Zebulun D. Horowitz
| The Reed Institute | Undergraduate Degree |
| New York University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Procter & Gamble Pharmaceuticals, Inc.
Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Procter & Gamble Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its products include Actonel, Asacol, Enablex, Didronel, Macrobid, Macrodantin, Entex, and Ziac. The firm manufactures and markets a variety of over-the-counter and oral care products such as Crest, Oral-B, Prilosec OTC, Vicks, Metamucil, Pepto-Bismol, ThermaCare, and other related products. The company was founded in 1970 and is headquartered in Cincinnati, OH. | Health Technology |
